|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01501 INT MEDICAL
Nominal 
27.400 +0.150 (+0.550%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 392,322 | 15.469% | 339,764 | 225,217 | 180,613 | 171,844 |
| Cost of Sales | (145,554) | 4.404% | (139,414) | (101,194) | (64,677) | (58,022) |
| Gross Profit | 246,768 | 23.168% | 200,350 | 124,023 | 115,936 | 113,822 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 652 | 35.551% | 481 | (637) | (30) | (13) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 110,749 | 25.258% | 88,417 | 56,829 | 59,864 | 76,519 | |
| Taxation | (11,571) | 46.246% | (7,912) | (6,704) | (8,570) | (11,818) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 1,360 | -- | (3) | 716 | (689) | 2,692 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 100,538 | 24.889% | 80,502 | 50,841 | 50,605 | 67,393 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (3,216) | -36.606% | (5,073) | (5,291) | (5,608) | (15,256) |
| Depreciation & Amortisation | 42,134 | 101.492% | 20,911 | 17,374 | 14,033 | 10,198 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | 58.000 | 20.833% | 48.000 | 31.000 | 30.000 | 41.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 9.538 | -- | 9.253 | 8.506 | 7.677 | 7.561 |
| Remarks: | Real time quote last updated: 02/12/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 100,538,000 |
| %Change | 24.889% |
| EPS / (LPS) | RMB 0.580 |
| NBV Per Share (¥) | RMB 9.538 |